Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The document concludes that choosing the right forehead and brow lifting technique based on individual patient characteristics is crucial to prevent complications and achieve desired results.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

Eyebrow lifts are effective for facial rejuvenation but may leave visible scars.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

SVF-PRP therapy effectively reverses hair loss effects.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.